Table 3.
Profile of Terlipressin usage for HRS-AKI patientsa
| Parameter | HRS n = 7 pts (9 patient records) |
Non HRS n = 9 pts (15 patient records) |
p value |
|---|---|---|---|
| Renal angina index | 10 (1–10) | 5 (5–8) | 0.06 |
| Creatinine 0 hb | 84 (48–116) | 67 (38–78) | 0.43 |
| Creatinine 12 hb | 36 (30–120) | 70 (48–108) | 0.53 |
| Creatinine 24 hb | 36 (17–41) | 58.5 (33–89.5) | 0.39 |
| Creatinine 48 hb | 29 (22–30) | 71 (37–96.5) | 0.32 |
| Creatinine 7 daysb | 28 (23–29) | 65.5 (25–85.5) | 0.32 |
| Urine output 0 hbc | 0.6 (0–1.1) | 0.1 (0–4) | 0.43 |
| Urine output 6 hbc | 2.6 (0.2–5.0) | 0.2 (0–1.9) | 0.1 |
| Urine output 12 hbc | 1.5 (0–3.0) | 0 (0–1) | 0.392 |
| Urine output 24 hbc | 0.9 (0–1.8) | 0.3 (0–1.7) | 0.42 |
| Urine output 48 hcb | 3 (0–3) | 2 (0–2) | 0.029 |
| Urine output 7 daysbc | 2 (0–2) | 3 (0–4) | 0.306 |
| Sodium 0 hdc | 141 (136–152) | 138 (135–139) | 0.202 |
| Sodium 12 hdc | 150.5 (143–158) | 136.4 (134.6–139) | 0.191 |
| Sodium 24 hdc | 143 (137.5–155) | 137 (135–138) | 0.259 |
| Sodium 48 hdc | 138 (135–139) | 140 (136–144) | 0.354 |
| Sodium 7 dayscd | 138 (137–138) | 138 (137–142) | 0.696 |
| Mortality | 40% | 50% | 0.55 |
apatient administration records; bexpressed as (median)(IQR); Cr Creatinine expressed in μmol/L;cb in ml/kg/hr.; dc in meq/litre